The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance
Article Figures & Tables
Figures
- Figure 1
C-peptide during OGTTs performed on and off IV-I therapy. Values are adjusted mean C-peptide ± standard errors of the mean (n = 37 paired OGTTs).
- Figure 2
Relationship between fasting and stimulated C-peptide (nanograms per milliliter) off insulin (panel A) and on IV-I (panel B) (n = 37 paired OGTTs).
- Figure 3
Glucose during OGTTs performed on and off IV-I therapy. Values are adjusted mean glucose ± standard errors of the mean (n = 37 paired OGTTs).
- Figure 4
Comparison of 2-h OGTT glucose levels off and on IV-I in each individual (n = 37 paired OGTTs).
Tables
- Table 1
Demographics of the subjects in each group
IV-I group (n = 30) SC-I group (n = 15) Age at randomization (years) 16.5 ± 12.4 20.1 ± 12.9 BMI 18.7 ± 4.2 20.4 ± 4.8 Sex Male 17 (56.7) 9 (60) Female 13 (43.3) 6 (40) Race/ethnicity Non-Hispanic white 29 (96.7) 15 (100) Unknown 1 (3.3) Impaired glucose tolerance 12 (40) 6 (40) Values are mean ± SD or n (%).
In this Issue
May 2015, 38(5)
The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance
